A Massachusetts joint legislative committee held a hearing on Tuesday to discuss an initiative that would legalize psychedelics that may appear on the November ballot if lawmakers decline to independently enact it first.
Members of the Special Joint Committee on Initiative Petitions took testimony from subject matter experts, supporters and opponents of the measure, which is being spearheaded by the campaign Massachusetts for Mental Health Options (MMHO).
This hearing comes about three months after Secretary of the Commonwealth William Galvin’s (D) office certified that activists had collected 96,277 valid signatures for the reform measure—about 20,000 more than required to force consideration by the legislature.
If lawmakers decide not to legalize psychedelics by May 1, activists would then have until July 3 to submit at least 12,429 additional valid signatures to put the proposal before voters on the November ballot.
At Tuesday’s hearing, the manager of Oregon Psilocybin Services (OPS), a division of the Oregon Health Authority (OHA) that oversees the state’s novel psychedelics program, offered neutral testimony on the Massachusetts initiative for informational purposes.
She described her state’s licensing process, training requirements for facilitators and how psilocybin is administered to clients.
“In Oregon, we understand that we must balance thousands
Read full article on Marijuana Moment
